Founded in 1994, Theralase Technologies Inc. designs, develops and manufactures super-pulsed, cold laser technology for a wide range of human, companion animal and equine applications. Theralase is committed to provide cutting-edge pre-clinical and clinical research to remain the most clinically and scientifically supported therapeutic medical laser on the market. The highly trained Theralase team continuously brings our valued customers the most advanced technology on the market, superior customer service, the latest interactive training and the most up to date clinical protocols to accelerate the success of their practice.
Bio-stimulative capabilities of Theralase laser systems include: healing neural muscular skeletal conditions through pain elimination, inflammation reduction and increased tissue regeneration. Combining Theralase laser technology with photodynamic compounds (PDCs) leads to bio-destructive capabilities, including destruction of cancer cells, bacteria, viruses and fat cells. Theralase lasers penetrate deeper - up to 10 cm (4 in) below the skin surface - and heal tissue faster than any other cold laser on the market. Theralase customers benefit from access to continuous advancements, as well as support and training from highly trained professionals.
In addition to the development and provision of laser technology, Theralase operates a full service medical rehabilitation clinic in Toronto, Ontario for training and education of health-care practitioners.